The Tisch Cancer Institute (TCI), a National Cancer Institute-designated center provides multidisciplinary approach to cancer treatments and clinical breakthroughs that may one day put an end to cancer.
The Institute was established in 2008, through the generosity of James and Merryl Tisch. Since that time, TCI has recruited more than 55 prominent researchers and physicians whose expertise spans basic, clinical, and population science research. Together they have developed innovative and translational research programs that build upon Mount Sinai’s history of medical breakthroughs to offer new hope for those at risk for or living with cancer.
The Tisch Cancer Institute plays a key role in the Mount Sinai Health System, which is one of the largest health care systems in the nation, and is a vital component of the Icahn School of Medicine at Mount Sinai. The Institute is on the forefront of medical and scientific training, biomedical research, and patient care.